Pfizer
Biotech

How Jeff Legos builds Pfizer’s oncology future

For the closely watched PD-1xVEGF competition, Jeff Legos’ strategy for Pfizer is anchored by three pillars: speed, breadth and novel combinations.
Angus Liu Mar 4, 2026 2:00pm
pipeline pipes RD research

Bayer ditches 1 AAV gene therapy from Pompe disease pair

Mar 4, 2026 9:59am
How physiology powers biotech innovation

How physiology powers biotech innovation

Brought to you by American Physiological Society
A ballpoint pen rests on top of a stack of documents ready for signing

UCB enters TCE space with $1.1B deal for autoimmune candidate

Mar 4, 2026 8:20am
Seoul South Korea

Roche pumps $480M into South Korea biopharma industry

Mar 4, 2026 11:22am
Row house England

UK invests $64M to expand trials to underserved communities

Mar 4, 2026 10:51am
More News

ARPA-H launches $158M effort for first lymphatic meds

Mar 4, 2026 8:55am

Teva's $400M Blackstone deal to fund Sanofi-partnered IBD drug

Mar 4, 2026 3:07am
Fierce Pharma

Sanofi inks $1.5B deal for Sino Biopharm's novel asset

Mar 4, 2026 3:00am

Ono’s Deciphera drops early-stage solid tumor drug

Mar 3, 2026 7:47pm